Detalhe da pesquisa
1.
Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor.
Immunity
; 38(2): 275-84, 2013 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23333074
2.
Highly specific and potently activating Vγ9Vδ2-T cell specific nanobodies for diagnostic and therapeutic applications.
Clin Immunol
; 169: 128-138, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27373969
3.
Endocytosis of EGFR requires its kinase activity and N-terminal transmembrane dimerization motif.
J Cell Sci
; 126(Pt 21): 4900-12, 2013 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23943881
4.
Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effects.
Proc Natl Acad Sci U S A
; 109(41): 16642-7, 2012 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-23012408
5.
A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies.
Cell Rep Med
; 4(3): 100961, 2023 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36868236
6.
A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell-Mediated Immune Response against EGFR-Expressing Tumors.
Cancer Immunol Res
; 11(9): 1237-1252, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37368791
7.
Rapid visualization of human tumor xenografts through optical imaging with a near-infrared fluorescent anti-epidermal growth factor receptor nanobody.
Mol Imaging
; 11(1): 33-46, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22418026
8.
Directing HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodies.
Sci Rep
; 12(1): 13413, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35927444
9.
Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors.
Nat Cancer
; 3(4): 418-436, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35469014
10.
A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth.
Int J Cancer
; 129(8): 2013-24, 2011 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21520037
11.
Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET.
Eur J Nucl Med Mol Imaging
; 38(4): 753-63, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21210114
12.
A Bispecific Antibody Antagonizes Prosurvival CD40 Signaling and Promotes Vγ9Vδ2 T cell-Mediated Antitumor Responses in Human B-cell Malignancies.
Cancer Immunol Res
; 9(1): 50-61, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33177109
13.
MCLA-117, a CLEC12AxCD3 bispecific antibody targeting a leukaemic stem cell antigen, induces T cell-mediated AML blast lysis.
Expert Opin Biol Ther
; 19(7): 721-733, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31286786
14.
The architecture of EGFR's basal complexes reveals autoinhibition mechanisms in dimers and oligomers.
Nat Commun
; 9(1): 4325, 2018 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30337523
15.
Nanobodies in therapeutic applications.
Curr Opin Mol Ther
; 9(4): 327-35, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17694445
16.
A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells.
Oncoimmunology
; 7(1): e1375641, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29296532
17.
High affinity nanobodies against human epidermal growth factor receptor selected on cells by E. coli display.
MAbs
; 8(7): 1286-1301, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27472381
18.
Combining somatic mutations present in different in vivo affinity-matured antibodies isolated from immunized Lama glama yields ultra-potent antibody therapeutics.
Protein Eng Des Sel
; 29(4): 123-33, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26945588
19.
Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform.
MAbs
; 7(4): 693-706, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26018625
20.
Regulation of Tiam1-Rac signalling.
FEBS Lett
; 546(1): 11-6, 2003 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-12829230